Treatment of vascular retinal disease with pentoxifylline: A controlled, randomized trial

Angiology

Volumn 53, Issue SUPPL. 1, 2002, Pages

  Incandela, L ^a   Cesarone, M R ^a   Belcaro, G ^a   Steigerwalt, R ^a   De Sanctis, M T ^a   Nicolaides, A N ^a   Griffin, M ^a   Geroulakos, G ^a   Ramaswami, G ^a  

^a PAP/PEA Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; PLACEBO;

ADULT; ARTICLE; BLINDNESS; BLOOD FLOW VELOCITY; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW;

BLOOD FLOW VELOCITY; FEMALE; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; PENTOXIFYLLINE; RETINAL ARTERY; RETINAL ARTERY OCCLUSION; TIME FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES; VASODILATOR AGENTS;

EID: 0036169772     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Retinal Duplex scanning in cerebrovascular disease and hypertension
2. Doppler ultrasonography of the central retinal artery in patients with diabetes and vascular disease treated with topical timolol
3. Planning clinical trials evaluating treatment in peripheral vascular disease due to atherosclerosis
4. Pentoxifylline (Oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disease
5. Oxpentifylline treatment of venous ulcers of the leg
6. Oxpentifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication